GoodRx Holdings Statistics
Total Valuation
GoodRx Holdings has a market cap or net worth of $1.16 billion. The enterprise value is $1.43 billion.
Important Dates
The last earnings date was Tuesday, November 4, 2025, after market close.
| Earnings Date | Nov 4, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
GoodRx Holdings has 347.45 million shares outstanding. The number of shares has decreased by -5.60% in one year.
| Current Share Class | 105.47M |
| Shares Outstanding | 347.45M |
| Shares Change (YoY) | -5.60% |
| Shares Change (QoQ) | -2.62% |
| Owned by Insiders (%) | 3.57% |
| Owned by Institutions (%) | 18.22% |
| Float | 86.39M |
Valuation Ratios
The trailing PE ratio is 38.50 and the forward PE ratio is 18.99. GoodRx Holdings's PEG ratio is 1.47.
| PE Ratio | 38.50 |
| Forward PE | 18.99 |
| PS Ratio | 1.53 |
| Forward PS | 1.41 |
| PB Ratio | 1.89 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | 6.53 |
| P/OCF Ratio | 6.44 |
| PEG Ratio | 1.47 |
Financial Ratio HistoryEnterprise Valuation
The stock's EV/EBITDA ratio is 11.13, with an EV/FCF ratio of 8.06.
| EV / Earnings | 44.99 |
| EV / Sales | 1.78 |
| EV / EBITDA | 11.13 |
| EV / EBIT | 13.82 |
| EV / FCF | 8.06 |
Financial Position
The company has a current ratio of 3.11, with a Debt / Equity ratio of 0.91.
| Current Ratio | 3.11 |
| Quick Ratio | 2.62 |
| Debt / Equity | 0.91 |
| Debt / EBITDA | 3.99 |
| Debt / FCF | 3.07 |
| Interest Coverage | 2.37 |
Financial Efficiency
Return on equity (ROE) is 4.90% and return on invested capital (ROIC) is 5.41%.
| Return on Equity (ROE) | 4.90% |
| Return on Assets (ROA) | 4.82% |
| Return on Invested Capital (ROIC) | 5.41% |
| Return on Capital Employed (ROCE) | 9.04% |
| Revenue Per Employee | $1.08M |
| Profits Per Employee | $43,027 |
| Employee Count | 738 |
| Asset Turnover | 0.60 |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, GoodRx Holdings has paid $22.00 million in taxes.
| Income Tax | 22.00M |
| Effective Tax Rate | 40.93% |
Stock Price Statistics
The stock price has decreased by -43.27% in the last 52 weeks. The beta is 1.46, so GoodRx Holdings's price volatility has been higher than the market average.
| Beta (5Y) | 1.46 |
| 52-Week Price Change | -43.27% |
| 50-Day Moving Average | 4.07 |
| 200-Day Moving Average | 4.41 |
| Relative Strength Index (RSI) | 33.94 |
| Average Volume (20 Days) | 5,161,922 |
Short Selling Information
The latest short interest is 8.25 million, so 2.38% of the outstanding shares have been sold short.
| Short Interest | 8.25M |
| Short Previous Month | 6.27M |
| Short % of Shares Out | 2.38% |
| Short % of Float | 9.55% |
| Short Ratio (days to cover) | 1.45 |
Income Statement
In the last 12 months, GoodRx Holdings had revenue of $800.65 million and earned $31.75 million in profits. Earnings per share was $0.09.
| Revenue | 800.65M |
| Gross Profit | 748.33M |
| Operating Income | 103.35M |
| Pretax Income | 53.75M |
| Net Income | 31.75M |
| EBITDA | 128.31M |
| EBIT | 103.35M |
| Earnings Per Share (EPS) | $0.09 |
Full Income StatementBalance Sheet
The company has $273.53 million in cash and $545.14 million in debt, giving a net cash position of -$271.61 million or -$0.78 per share.
| Cash & Cash Equivalents | 273.53M |
| Total Debt | 545.14M |
| Net Cash | -271.61M |
| Net Cash Per Share | -$0.78 |
| Equity (Book Value) | 600.71M |
| Book Value Per Share | 1.76 |
| Working Capital | 383.66M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was $179.76 million and capital expenditures -$2.44 million, giving a free cash flow of $177.32 million.
| Operating Cash Flow | 179.76M |
| Capital Expenditures | -2.44M |
| Free Cash Flow | 177.32M |
| FCF Per Share | $0.51 |
Full Cash Flow StatementMargins
Gross margin is 93.46%, with operating and profit margins of 12.91% and 3.97%.
| Gross Margin | 93.46% |
| Operating Margin | 12.91% |
| Pretax Margin | 6.71% |
| Profit Margin | 3.97% |
| EBITDA Margin | 16.03% |
| EBIT Margin | 12.91% |
| FCF Margin | 22.15% |
Dividends & Yields
GoodRx Holdings does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | 5.60% |
| Shareholder Yield | 5.60% |
| Earnings Yield | 2.74% |
| FCF Yield | 15.33% |
Dividend DetailsAnalyst Forecast
The average price target for GoodRx Holdings is $5.75, which is 72.67% higher than the current price. The consensus rating is "Buy".
| Price Target | $5.75 |
| Price Target Difference | 72.67% |
| Analyst Consensus | Buy |
| Analyst Count | 8 |
| Revenue Growth Forecast (5Y) | 5.93% |
| EPS Growth Forecast (5Y) | 89.57% |
Stock ForecastsFair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside | |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 6 |
